megestrol acetate has been researched along with tamoxifen in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (26.17) | 18.7374 |
| 1990's | 40 (37.38) | 18.2507 |
| 2000's | 29 (27.10) | 29.6817 |
| 2010's | 10 (9.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Blamey, RW; Chan, S; Dixon, AR; Haybittle, J; Jackson, L | 1 |
| Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
| Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
| Daniel, F; Rao, DG; Tyrrell, CJ | 1 |
| Brenner, BG; Margolese, RG | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR | 2 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, LP; Smaldone, L | 1 |
| Dahrouge, S; Fine, S; Hanson, J; McDermot, RS; Paterson, AH; Pritchard, KI; Sansregret, E; Stewart, DJ; Trudeau, M; White, DF | 1 |
| Fellowes, G; Larsen, W; Rickman, LS | 1 |
| Hunter, RE; Longcope, C; Reale, FR; Rose, PG | 1 |
| Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J | 1 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
| Blamey, RW; Morgan, DA; Nicholson, RI; Robertson, JF; Todd, J; Williams, MR | 1 |
| Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
| Glick, JH; Haller, DG | 1 |
| Allegra, J; Bertino, JR; Bonomi, P; Browder, H; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Ettinger, DS | 1 |
| Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Twining, P; Williams, MR | 1 |
| Sedlacek, SM | 1 |
| Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB | 1 |
| Badger, G; Belinson, JL; McClure, M | 1 |
| Anderson, K; Bonomi, P; Economou, S; Gale, M; Johnson, P; Von Roenn, J; Wolter, J | 1 |
| Anderson, KM; Bonomi, PD; Economou, SG; Gale, M; Von Roenn, JH; Wolter, JM | 1 |
| Alexieva-Figusch, J; Schrijver, J; van Breederode, N; van Gilse, HA | 1 |
| Allegra, JC | 1 |
| Lamberts, SW; van Koetsveld, P; Verleun, T | 1 |
| Hodder, RV; Hughes, E | 1 |
| Albert, J; Berry, CC; Fay, W; Geller, J; Liu, J; Weis, P | 1 |
| Anderson, KM; Bonomi, PD; Economou, SG; Johnson, PA; Wolter, JM | 1 |
| Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Richards, F; Stuart, JJ | 1 |
| Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L | 1 |
| Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
| Benghiat, A; Cassidy, SA; Davidson, HE; Mancero, FS; Pickard, JG; Tyrrell, CJ | 1 |
| Morgan, LR | 1 |
| Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL | 1 |
| Blumenschein, GR; Buzdar, AU; Ross, MB | 1 |
| Blumenschein, GR | 1 |
| Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW | 1 |
| Klijn, JG | 1 |
| Mizushima, Y; Murakami, T | 1 |
| Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB | 1 |
| Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D | 1 |
| Ahlgren, JD; Alt, D; Ellison, NM; Gottlieb, RJ; Laluna, F; Lokich, JJ; Sinclair, PR; Ueno, W; Wampler, GL; Yeung, KY | 1 |
| Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
| Harrison-Woolrych, M; Robinson, R | 1 |
| Blamey, RW; Cannon, P; Ellis, IO; Gee, JM; Manning, DL; McClelland, RA; Nicholson, RI; Robertson, JF | 1 |
| Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R | 1 |
| Crawford, DJ; George, WD; Leake, RE; Paul, J; Smith, DC; Stewart, M | 1 |
| Espie, M | 1 |
| Chao, AS; Hsueh, S; Lai, CH; Soong, YK | 1 |
| Beinfield, M; Fischer, D; Haffty, BG; McKhann, C; Wilmarth, L; Wilson, L | 1 |
| Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R | 1 |
| Borruto Caracciolo, G; Caccavale, C; Cardone, A; Di Serio, C; Tolino, A | 1 |
| Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS | 1 |
| Buzdar, AU; Hortobagyi, GN; Plourde, PV | 1 |
| Batist, G; Damian, S; Damian, Z; Georges, E; Jean-Claude, BJ; Leyland-Jones, B; Liu, Z; Mustafa, A; Panasci, L; Vasilescu, D | 1 |
| Blackledge, GR; Earl, H; Keen, C; Spooner, D; Stuart, NS; Taylor, AR; Tyrell, C; Warwick, J; Webster, DJ | 1 |
| Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B | 1 |
| Blamey, RW; Cheung, KL; Ellis, IO; Elston, CW; Nicholson, RI; Pinder, SE; Robertson, JF; Willsher, PC | 1 |
| Berstein, LM | 1 |
| Baider, L; Barak, V; Farbstein, H; Fridlender, ZG; Kalickman, I; Kaplan, A; Nisman, B; Peretz, T; Stephanos, S | 1 |
| Diamandis, EP; Helle, SI; Lonning, PE; Lundgren, S; Melegos, DN; Yu, H | 1 |
| Agelaki, S; Chalkiadakis, G; Georgoulias, V; Kakolyris, S; Kalbakis, K; Koukourakis, M; Samonis, G; Sanidas, E; Tsiftsis, D; Vlachonicolis, J | 1 |
| Benson, S; Cella, D; Fallowfield, LJ; Howell, A; Leaity, SK | 1 |
| Bernhard, J; Bonnefoi, H; Castiglione-Gertsch, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hürny, C; Morant, R; Schmitz, SF; Thürlimann, B | 1 |
| Bland, KI; Buzdar, AU | 1 |
| Bland, KI | 1 |
| Arkhipov, A; Bajetta, E; Cervek, J; di Salle, E; Dirix, LY; Dugardyn, JL; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Mennel, RG; Miller, LL; Nasurdi, C; Piscitelli, G; Polli, A; Zilembo, N | 1 |
| Bajetta, E; Cervek, J; Di Salle, E; Dirix, LY; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Piscitelli, G; Polli, A | 1 |
| Bonte, J | 1 |
| Buzdar, AU | 1 |
| Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
| Ingle, JN | 1 |
| Kegg, S; Lau, R | 1 |
| Bydder, SA; Spry, NA | 1 |
| Ceccherini, R; Dellach, C; Leita, ML; Milani, S; Muggia, M; Mustacchi, G | 1 |
| Deavers, MT; Gershenson, DM; Malpica, A; Parlow, AF; Silva, EG | 1 |
| Parker, LM; Piccart, M; Pritchard, KI | 1 |
| Rose, C | 1 |
| Guzman, RC; Nandi, S; Rajkumar, L; Talamantes, F; Thordarson, G; Yang, J | 1 |
| Herzog, TJ | 1 |
| Andersen, W; Brunetto, VL; Fiorica, JV; Hanjani, P; Lentz, SS; Mannel, R | 1 |
| Campos, SM | 1 |
| Carlström, K; Fornander, T; Löfgren, L; Rutqvist, LE; von Schoultz, B; von Schoultz, E; Wallberg, B; Wilking, N | 1 |
| Ingle, JN; Suman, VJ | 1 |
| Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T | 1 |
| Pritchard, KI; Wong, NS | 1 |
| Cheung, KL; Owers, R; Robertson, JF | 1 |
| DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
| Fjøsne, HE; Jacobsen, AB; Lundgren, S | 1 |
| Daniele, B; De Maio, E; Di Maio, M; Gallo, C; Morabito, A; Perrone, F; Piccirillo, MC; Pignata, S | 1 |
| Albain, KS; Bearden, JD; Giguere, JK; Goodwin, JW; Green, SJ; Jiang, CS; Lippman, SM; Martino, S; Moinpour, CM | 1 |
| Andersen, J; Cold, S; Ejlertsen, B; Ewertz, M; Jacobsen, EH; Jensen, D; Kamby, C; Møller, KA; Møller, S; Philip, P | 1 |
| Audhuy, B; El-Hariry, I; Gardner, JP; Gore, M; Harper, P; Hawkins, R; Machiels, JP; Pétavy, F; Ravaud, A; Rolland, F; Schöffski, P; von der Maase, H; Zantl, N | 1 |
| Jonsson, H; Kemetli, L; Lenner, P; Nyström, L; Rutqvist, LE; Törnberg, S | 1 |
| Brown, C; De Souza, P; Fox, P; Gebski, V; Hudson, M; Lee, CK; Lord, S | 1 |
| Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL | 1 |
| Carlström, K; Fahlén, M; Löfgren, L; Naessén, S; Söderqvist, G; von Schoultz, E | 1 |
| Buist, MR; Kenter, GG; van der Velden, J; van Driel, WJ; van Lonkhuijzen, LR; van Meurs, HS | 1 |
| Chang, YJ; Lai, SW; Lee, CW; Morisky, DE; Muo, CH; Wang, IK; Yang, SP | 1 |
| Behbakht, K; Birrer, MJ; Burke, JJ; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Myers, AP; Pearl, M; Van Hummelen, P; Zhang, Y; Zweizig, S | 1 |
| Churchman, M; Dawson, C; Gourley, C; Herrington, CS; Hollis, RL; Mackean, MJ; Nunes, H; Nussey, F; Rye, T; Stanley, B; Towler, JD; Yan, X | 1 |
13 review(s) available for megestrol acetate and tamoxifen
| Article | Year |
|---|---|
Overview of hormonal therapy in advanced breast cancer.
Topics: Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Meta-Analysis as Topic; Tamoxifen | 1990 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
An overview of megestrol acetate for the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Megestrol; Megestrol Acetate; Menopause; National Institutes of Health (U.S.); Tamoxifen; United States | 1988 |
[Drug induced obesity].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents, Hormonal; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Male; Megestrol; Megestrol Acetate; Obesity; Psychotropic Drugs; Tamoxifen | 1995 |
[Megestrol acetate as hormone therapy in oncology].
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Humans; Medroxyprogesterone; Megestrol Acetate; Neoplasms, Hormone-Dependent; Progesterone Congeners; Tamoxifen | 1998 |
Third generation aromatase inhibitors in metastatic breast cancer patients failing tamoxifen. Randomized comparisons with megestrol acetate: a critical review.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Megestrol Acetate; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Failure; Treatment Outcome | 2000 |
A summary of second-line randomized studies of aromatase inhibitors.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2001 |
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer.
Topics: Aged; Aromatase Inhibitors; Breast Neoplasms; Down-Regulation; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Tamoxifen | 2003 |
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
Aromatase inhibitors for breast cancer in postmenopausal women.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2004 |
Aromatase inhibitors for therapy of advanced breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Drug Evaluation; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles | 2005 |
A review of exemestane in the management of breast cancer.
Topics: Administration, Oral; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Megestrol Acetate; Multicenter Studies as Topic; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 2005 |
Is human hepatocellular carcinoma a hormone-responsive tumor?
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Evidence-Based Medicine; Gonadal Steroid Hormones; Humans; Liver Neoplasms; Megestrol Acetate; Meta-Analysis as Topic; Neoplasms, Hormone-Dependent; Patient Selection; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Receptors, Steroid; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2008 |
36 trial(s) available for megestrol acetate and tamoxifen
| Article | Year |
|---|---|
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
Topics: Breast Neoplasms; Drug Resistance; Female; Humans; Megestrol; Megestrol Acetate; Mitoxantrone; Neoplasm Staging; Probability; Prospective Studies; Receptors, Estrogen; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Topics: Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1990 |
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Random Allocation; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1986 |
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen | 1988 |
Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
Topics: Adult; Carcinoma; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Random Allocation; Tamoxifen | 1987 |
Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1987 |
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Tamoxifen | 1985 |
Metastatic breast cancer: preliminary results with oral hormonal therapy.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1985 |
LHRH-agonist treatment in clinical and experimental human breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen | 1985 |
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
Topics: Adenocarcinoma; Aminoglutethimide; Carcinoma; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Ovarian Neoplasms; Palliative Care; Tamoxifen | 1993 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Goserelin; Humans; Ki-67 Antigen; Megestrol; Megestrol Acetate; Menopause; Neoplasm Proteins; Nuclear Proteins; Postmenopause; Premenopause; Prognosis; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1994 |
Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Survival Rate; Tamoxifen; Treatment Outcome | 1994 |
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Retrospective Studies; Tamoxifen | 1994 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen | 1993 |
Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Interferon-beta; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1995 |
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles | 1996 |
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1996 |
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Survival Rate; Tamoxifen; Time Factors; Treatment Failure | 1996 |
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure | 1997 |
Changes in cytokine production of breast cancer patients treated with interferons.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Cytokines; Female; Humans; Interferon-beta; Interferon-gamma; Interleukin-1; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Interleukin-2; Recombinant Proteins; Tamoxifen | 1998 |
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Estrogen Antagonists; Female; Humans; Megestrol Acetate; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Staging; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine | 1999 |
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Quality of Life; Tamoxifen; Treatment Failure | 1999 |
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Pain; Postmenopause; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial.
Topics: Androstadienes; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Postmenopause; Survival Analysis; Tamoxifen; Treatment Failure | 2000 |
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Probability; Risk Assessment; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen; Vinblastine; Vinorelbine | 2002 |
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Differentiation; Down-Regulation; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Receptors, Progesterone; Tamoxifen | 2004 |
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Insulin-Like Growth Factor I; Megestrol Acetate; Middle Aged; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Tamoxifen; Testosterone | 2004 |
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Tamoxifen; Treatment Outcome | 2006 |
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Survival Analysis; Tamoxifen; Time Factors | 2008 |
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Hot Flashes; Humans; Megestrol Acetate; Menopause; Middle Aged; Placebos; Tamoxifen | 2008 |
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Megestrol Acetate; Middle Aged; Postmenopause; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome | 2008 |
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Disease-Free Survival; ErbB Receptors; Female; Humans; Immunohistochemistry; Kidney Neoplasms; Lapatinib; Male; Megestrol Acetate; Middle Aged; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Tamoxifen | 2008 |
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Renal Cell; Female; Humans; Inflammation; Kaplan-Meier Estimate; Kidney Neoplasms; Lapatinib; Leukocyte Count; Male; Megestrol Acetate; Middle Aged; Platelet Count; Prognosis; Quinazolines; Serum Albumin; Tamoxifen; Young Adult | 2013 |
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen | 2014 |
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Topics: Class I Phosphatidylinositol 3-Kinases; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Mutation; Phosphatidylinositol 3-Kinases; Prospective Studies; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sirolimus; Tamoxifen; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2016 |
58 other study(ies) available for megestrol acetate and tamoxifen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
A pilot study of stanozolol for advanced breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Megestrol; Megestrol Acetate; Middle Aged; Pilot Projects; Remission Induction; Stanozolol; Tamoxifen | 1991 |
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen | 1991 |
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen | 1990 |
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen | 1990 |
Life-threatening hypercalcemia and tamoxifen.
Topics: Aged; Calcitonin; Female; Humans; Hydrocortisone; Hypercalcemia; Megestrol; Megestrol Acetate; Prednisone; Sodium Chloride; Tamoxifen | 1990 |
Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen | 1990 |
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis.
Topics: Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Kinetics; Male; Megestrol; Megestrol Acetate; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Tamoxifen | 1986 |
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1989 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Prospective Studies; Tamoxifen; Viscera | 1988 |
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Retrospective Studies; Tamoxifen | 1988 |
Sequential hormone therapy for advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Soft Tissue Neoplasms; Tamoxifen | 1988 |
Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catecholamines; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Nutritional Status; Pyridoxine; Steroids; Tamoxifen; Trace Elements | 1987 |
Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Topics: Animals; Cells, Cultured; Dexamethasone; Estradiol; Estrenes; Megestrol; Megestrol Acetate; Mifepristone; Pituitary Neoplasms; Progesterone; Prolactin; Rats; Rats, Inbred BUF; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Tamoxifen | 1987 |
Pulmonary lymphangiomyomatosis complicating pregnancy. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chylothorax; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Lymphoproliferative Disorders; Megestrol; Megestrol Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Tamoxifen | 1987 |
Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level.
Topics: Aged; Dihydrotestosterone; Epithelium; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Prostate; Protein Biosynthesis; Tamoxifen | 1987 |
Megestrol acetate: first-line therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Retrospective Studies; Tamoxifen | 1986 |
Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Carcinoma; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Tamoxifen; Time Factors | 1986 |
Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen | 1985 |
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen | 1982 |
The role of progestins in the treatment of breast cancer.
Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1983 |
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone | 1984 |
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments.
Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen | 1984 |
Experience with hormonal therapy in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate | 1995 |
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Fibroid growth in response to high-dose progestogen.
Topics: Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Megestrol; Megestrol Acetate; Middle Aged; Progestins; Tamoxifen; Ultrasonography; Uterine Neoplasms | 1995 |
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1994 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Pregnancy; Tamoxifen | 1994 |
Aromatase inhibitors in metastatic breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles | 1996 |
Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate.
Topics: Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Megestrol Acetate; Tamoxifen; Tumor Cells, Cultured | 1996 |
Predictors of response to second-line endocrine therapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gonanes; Goserelin; Humans; Megestrol Acetate; Middle Aged; Nitriles; Ovariectomy; Predictive Value of Tests; Remission Induction; Tamoxifen; Triazoles | 1997 |
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Megestrol Acetate; Middle Aged; Multivariate Analysis; Progestins; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Survival Analysis; Tamoxifen | 1999 |
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Evaluation Studies as Topic; Female; Hormone Replacement Therapy; Humans; Megestrol Acetate; Menopause; Middle Aged; Nitriles; Pilot Projects; Quality of Life; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles | 1999 |
Safety and tolerability of endocrine therapies used in the treatment of advanced breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Tolerance; Female; Humans; Megestrol Acetate; Nitriles; Safety; Tamoxifen; Triazoles | 1999 |
Future directions in endocrine treatment of advanced breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Megestrol Acetate; Nitriles; Tamoxifen; Triazoles | 1999 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |
Estrogen as therapy for breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase II as Topic; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Salvage Therapy; Tamoxifen; Treatment Outcome; Triazoles | 2002 |
Tamoxifen in antiretroviral-associated gynaecomastia.
Topics: Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Estrogen Receptor Modulators; Gynecomastia; HIV Infections; Humans; Male; Megestrol Acetate; Reverse Transcriptase Inhibitors; Tamoxifen; Viral Load | 2002 |
Treatment for hot flushes in women receiving tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2002 |
Calcifications in ovary and endometrium and their neoplasms.
Topics: Animals; Calcinosis; Chorionic Gonadotropin; Clomiphene; Dihydrotestosterone; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Female; Growth Hormone; Guinea Pigs; Hormones; Megestrol Acetate; Ovarian Neoplasms; Ovary; Prolactin; Tamoxifen; Testosterone | 2003 |
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.
Topics: 2-Methoxyestradiol; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Mammary Neoplasms, Animal; Megestrol Acetate; Methylnitrosourea; Norethindrone; Progesterone; Progestins; Rats; Rats, Inbred Lew; Tamoxifen; Time Factors; Treatment Outcome | 2004 |
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Synergism; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Progesterone; Tamoxifen | 2004 |
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome | 2005 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Ovariectomy; Sweden; Tamoxifen | 2009 |
Megestrol acetate may stimulate the production of insulin-like growth factor 1 in breast tissues of women with breast cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Female; Humans; Insulin-Like Growth Factor I; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Tamoxifen | 2013 |
Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Goserelin; Granulosa Cell Tumor; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Ovarian Neoplasms; Ovariectomy; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Salpingectomy; Tamoxifen; Triazoles | 2015 |
Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: A retrospective population-based time-dependent cohort study.
Topics: Adult; Aged; Aromatase Inhibitors; Breast Neoplasms; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Megestrol Acetate; Middle Aged; Morphine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Tamoxifen; Young Adult | 2015 |
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; CA-125 Antigen; Cystadenocarcinoma, Serous; Female; Humans; Letrozole; Megestrol Acetate; Membrane Proteins; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Predictive Value of Tests; Receptors, Estrogen; Retrospective Studies; Tamoxifen | 2019 |